NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD
NASDAQ:DRIO (4/17/2025, 8:14:08 PM)
0.75
+0.05 (+7.14%)
The current stock price of DRIO is 0.75 USD. In the past month the price increased by 6.32%. In the past year, price decreased by -35.34%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 32.67 | 35.14B | ||
DOCS | DOXIMITY INC-CLASS A | 41.57 | 9.98B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 6.27B | ||
CERT | CERTARA INC | 31.44 | 2.28B | ||
SDGR | SCHRODINGER INC | N/A | 1.88B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 13.59 | 1.72B | ||
PHR | PHREESIA INC | N/A | 1.41B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.20B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
EVH | EVOLENT HEALTH INC - A | 13.58 | 1.04B | ||
HSTM | HEALTHSTREAM INC | 49.08 | 988.87M | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 787.15M |
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company is headquartered in New York City, New York and currently employs 196 full-time employees. The company went IPO on 2013-03-08. The firm operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
DARIOHEALTH CORP
322 W 57Th St. #33B
New York City NEW YORK 10019 US
CEO: Erez Raphael
Employees: 223
Company Website: https://shop.mydario.com/
Investor Relations: https://dariohealth.investorroom.com
Phone: 16466654667
The current stock price of DRIO is 0.75 USD. The price increased by 7.14% in the last trading session.
The exchange symbol of DARIOHEALTH CORP is DRIO and it is listed on the Nasdaq exchange.
DRIO stock is listed on the Nasdaq exchange.
9 analysts have analysed DRIO and the average price target is 2.72 USD. This implies a price increase of 262.67% is expected in the next year compared to the current price of 0.75. Check the DARIOHEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DARIOHEALTH CORP (DRIO) has a market capitalization of 31.18M USD. This makes DRIO a Nano Cap stock.
DARIOHEALTH CORP (DRIO) currently has 223 employees.
DARIOHEALTH CORP (DRIO) has a resistance level at 0.76. Check the full technical report for a detailed analysis of DRIO support and resistance levels.
The Revenue of DARIOHEALTH CORP (DRIO) is expected to grow by 20.99% in the next year. Check the estimates tab for more information on the DRIO EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DRIO does not pay a dividend.
DARIOHEALTH CORP (DRIO) will report earnings on 2025-05-13, before the market open.
DARIOHEALTH CORP (DRIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.62).
The outstanding short interest for DARIOHEALTH CORP (DRIO) is 10.06% of its float. Check the ownership tab for more information on the DRIO short interest.
ChartMill assigns a technical rating of 3 / 10 to DRIO. When comparing the yearly performance of all stocks, DRIO is a bad performer in the overall market: 69.06% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to DRIO. DRIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months DRIO reported a non-GAAP Earnings per Share(EPS) of -0.62. The EPS increased by 69.31% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -34.47% | ||
ROE | -56.9% | ||
Debt/Equity | 0.33 |
ChartMill assigns a Buy % Consensus number of 82% to DRIO. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 44.06% and a revenue growth 20.99% for DRIO